- COVID-19
- Biosimilars
- Cataract Therapeutics
- DME
- Gene Therapy
- Workplace
- Ptosis
- Optic Relief
- Imaging
- Geographic Atrophy
- AMD
- Presbyopia
- Ocular Surface Disease
- Practice Management
- Pediatrics
- Surgery
- Therapeutics
- Optometry
- Retina
- Cataract
- Pharmacy
- IOL
- Dry Eye
- Understanding Antibiotic Resistance
- Refractive
- Cornea
- Glaucoma
- OCT
- Ocular Allergy
- Clinical Diagnosis
- Technology
STAAR Surgical introduces ICL delivery system, practice building program
STAAR Surgical Co. announced a certification course for refractive surgeons for the company's implantable collamer lens (Visian ICL). The company also launched a micro-incision delivery system (nanoPOINT), which can inject the single-piece IOL through a 2.2-mm incision compared with the current requirement of a 2.8- to 3-mm incision.
STAAR Surgical Co. announced a certification course for refractive surgeons for the company'simplantable collamer lens (Visian ICL). The company also launched a micro-incision deliverysystem (nanoPOINT), which can inject the single-piece IOL through a 2.2-mm incision comparedwith the current requirement of a 2.8- to 3-mm incision.
In addition, STAAR Surgical's aspheric foldable IOL (Afinity Collamer, Model CQ2015A) recentlyreceived designation as a New Technology Intraocular Lens.
The company also introduced a nine-part ICL growth program for refractive surgeons. The Webseminar/conference call program features Brian Boxer Wachler, MD, and focuses on the keyelements required to build a successful ICL practice. The program is designed to helpinterested surgeons capitalize on the growing consumer awareness of the lens' benefits andcontinue its recent progress in the U.S. market.
For more information, visit STAAR Surgical at booth 1228.
